T Susanna Meijer
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 13, 2022
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.T Susanna Meijer, Jan H N Dieters, Eleonora M de Leede
|Aug 08, 2020
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.T Susanna Meijer, Mark C Burgmans, Eleonora M de Leede
|Jul 20, 2020
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma.T Susanna Meijer, Mark C Burgmans
|Feb 16, 2019
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.T Susanna Meijer, Mark C Burgmans, Marta Fiocco
Pageof 1
